Change
Tools:
Print this page Compare to last year's report

Consolidated statement of income


4th quarter

 

 

 

January - December

2012

 

2013

 

in € millions

 

2012

 

2013

 

 

 

 

 

 

 

 

 

Continuing operations

3,673

 

3,482

 

Revenue

 

15,390

 

14,590

(2,358)

 

(2,198)

 

Cost of sales

 

(9,591)

 

(8,951)

1,315

 

1,284

 

Gross profit

 

5,799

 

5,639

 

(139)

 

Impairment

 

(2,106)

 

(139)

(819)

 

(767)

 

Selling expenses

 

(3,192)

 

(3,023)

(358)

 

(380)

 

General and administrative expenses

 

(1,275)

 

(1,345)

(99)

 

(97)

 

Research and development expenses

 

(384)

 

(373)

(3)

 

215

 

Other operating income/(expenses)

 

(40)

 

199

36

 

116

 

Operating income

 

(1,198)

 

958

(38)

 

(48)

 

Net financing expenses

 

(205)

 

(200)

(1)

 

1

 

Results from associates and joint ventures

 

13

 

14

(3)

 

69

 

Profit before tax

 

(1,390)

 

772

16

 

(21)

 

Income tax

 

(203)

 

(111)

13

 

48

 

Profit for the period from continuing operations

 

(1,593)

 

661

 

 

 

 

 

 

 

 

 

Discontinued operations

 

 

 

 

(22)

 

16

 

Profit for the period from discontinued operations

 

(436)

 

131

(9)

 

64

 

Profit for the period

 

(2,029)

 

792

 

 

 

 

 

 

 

 

 

Attributable to

 

 

 

 

(27)

 

51

 

Shareholders of the company

 

(2,092)

 

724

18

 

13

 

Non-controlling interests

 

63

 

68

(9)

 

64

 

Profit for the period

 

(2,029)

 

792

Copyright © 2014 Akzo Nobel N.V.